{"disease":{"id":"adcc","name":"adcc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03554889","title":"Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":21,"lead_sponsor_name":"Hangzhou Cancer Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}